Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based...
Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Introduction
There is strong evidence from randomized controlled trials (RCTs) that second-generation antipsychotic (SGA) medications are associated with metabolic adverse events. However, with the recent increases in the use of SGAs worldwide and frequent off-label use, it is unclear whether these associations are generalizable to populations b...
Alternative Titles
Full title
Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2190922377
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2190922377
Other Identifiers
ISSN
0114-5916
E-ISSN
1179-1942
DOI
10.1007/s40264-017-0543-0
